These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9446035)

  • 21. [Inflammatory diseases of the intestines].
    Felley C; Guyot J; Hess J; Mottet C; Delarive J; Michetti P
    Rev Med Suisse; 2006 Jan; 2(49):191-4, 196-8, 201-3. PubMed ID: 16493962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesalamine derivatives in the treatment of Crohn's disease.
    Harrell LE; Hanauer SB
    Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infliximab (Remicade) for Crohn's disease.
    Med Lett Drugs Ther; 1999 Feb; 41(1047):19-20. PubMed ID: 10076592
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence.
    Buisson A; Chevaux JB; Bommelaer G; Peyrin-Biroulet L
    Dig Liver Dis; 2012 Jun; 44(6):453-60. PubMed ID: 22265329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Improved treatment of Crohn's disease].
    Nau JY
    Rev Med Suisse; 2005 May; 1(18):1241. PubMed ID: 15977716
    [No Abstract]   [Full Text] [Related]  

  • 27. Tumour-necrosis-factor antibody treatment in Crohn's disease.
    Derkx B; Taminiau J; Radema S; Stronkhorst A; Wortel C; Tytgat G; van Deventer S
    Lancet; 1993 Jul; 342(8864):173-4. PubMed ID: 8101267
    [No Abstract]   [Full Text] [Related]  

  • 28. [Medical treatment of Crohn's disease].
    Hiwatashi N
    Nihon Shokakibyo Gakkai Zasshi; 2000 Feb; 97(2):145-52. PubMed ID: 10707582
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of Crohn's Disease After Surgical Resection.
    Singh S; Nguyen GC
    Gastroenterol Clin North Am; 2017 Sep; 46(3):563-575. PubMed ID: 28838415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of therapy-resistant perineal metastatic Crohn's disease after proctectomy using anti-tumor necrosis factor chimeric monoclonal antibody, cA2: report of two cases.
    van Dullemen HM; de Jong E; Slors F; Tytgat GN; van Deventer SJ
    Dis Colon Rectum; 1998 Jan; 41(1):98-102. PubMed ID: 9510318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inducing remission of ulcerative colitis: are clinicians better equipped than ever?
    Armuzzi A; Felice C
    Expert Rev Gastroenterol Hepatol; 2013 Feb; 7(2):95-7. PubMed ID: 23363258
    [No Abstract]   [Full Text] [Related]  

  • 32. Beneficial effect of treatment with a monoclonal anti-tumor necrosis factor-alpha antibody on markers of coagulation and fibrinolysis in patients with active Crohn's disease.
    Hommes DW; van Dullemen HM; Levi M; van der Ende A; Woody J; Tytgat GN; van Deventer SJ
    Haemostasis; 1997; 27(6):269-77. PubMed ID: 9731107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody to tumor necrosis factor in the treatment of Crohn's disease.
    Stricker T; Braegger CP
    J Pediatr Gastroenterol Nutr; 1998 Sep; 27(3):369-70. PubMed ID: 9740217
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-TNF antibody treatment of Crohn's disease.
    van Deventer SJ
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I114-20. PubMed ID: 10577987
    [No Abstract]   [Full Text] [Related]  

  • 35. Monoclonal antibody approved for treatment of Crohn's disease.
    Freeman TR; Piascik P
    J Am Pharm Assoc (Wash); 1998; 38(6):770-2. PubMed ID: 9861797
    [No Abstract]   [Full Text] [Related]  

  • 36. Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.
    Mudter J; Neurath MF
    Gut; 2007 Feb; 56(2):293-303. PubMed ID: 16956919
    [No Abstract]   [Full Text] [Related]  

  • 37. Saccharomyces boulardii in maintenance treatment of Crohn's disease.
    Guslandi M; Mezzi G; Sorghi M; Testoni PA
    Dig Dis Sci; 2000 Jul; 45(7):1462-4. PubMed ID: 10961730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical options for treating Crohn's disease in adults: focus on antitumor necrosis factor-alpha chimeric monoclonal antibody.
    Wall GC; Heyneman C; Pfanner TP
    Pharmacotherapy; 1999 Oct; 19(10):1138-52. PubMed ID: 10512063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesalamine in the treatment of active Crohn's disease.
    Dignass A; Marteau P
    Gastroenterology; 2005 Jan; 128(1):245-6; author reply 246. PubMed ID: 15633152
    [No Abstract]   [Full Text] [Related]  

  • 40. Mesalamine maintenance therapy for Crohn's disease.
    Feagan BG; McDonald JW
    Gastroenterology; 2001 Feb; 120(2):585-6. PubMed ID: 11271451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.